These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19243478)

  • 1. DLQI scores in patients with keloids and hypertrophic scars: a prospective case control study.
    Balci DD; Inandi T; Dogramaci CA; Celik E
    J Dtsch Dermatol Ges; 2009 Aug; 7(8):688-92. PubMed ID: 19243478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dermatology life quality index as a means to assess life quality in patients with different scar types.
    Reinholz M; Poetschke J; Schwaiger H; Epple A; Ruzicka T; Gauglitz GG
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2112-9. PubMed ID: 25866177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis affects patient's quality of life more seriously in female than in male in Japan.
    Mabuchi T; Yamaoka H; Kojima T; Ikoma N; Akasaka E; Ozawa A
    Tokai J Exp Clin Med; 2012 Sep; 37(3):84-8. PubMed ID: 23032250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis.
    He Z; Lu C; Basra MK; Ou A; Yan Y; Li L
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):109-15. PubMed ID: 22145712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect on quality of life in patients with pityriasis rosea: is it associated with rash severity?
    Chuh AA; Chan HH
    Int J Dermatol; 2005 May; 44(5):372-7. PubMed ID: 15869534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of keloids and hypertrophic scars using topical and intralesional mitomycin C.
    Seo SH; Sung HW
    J Eur Acad Dermatol Venereol; 2012 May; 26(5):634-8. PubMed ID: 21651620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring quality of life in patients with psoriasis using the Arabic version for Morocco of the Dermatology Life Quality Index.
    Khoudri I; Lamchahab FZ; Ismaili N; Senouci K; Hassam B; Abouqal R
    Int J Dermatol; 2013 Jul; 52(7):795-802. PubMed ID: 23488573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of Fas protein expression in hypertrophic scar and keloid.
    Lu F; Gao JH; Li XJ
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Mar; 23(3):228-9, 232. PubMed ID: 12651236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hypertrophic scars and keloids.
    Kaartinen I
    Duodecim; 2016; 132(16):1439-47. PubMed ID: 29188931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical management decisions are related to the impact of psoriasis on patient-rated quality of life.
    Katugampola RP; Hongbo Y; Finlay AY
    Br J Dermatol; 2005 Jun; 152(6):1256-62. PubMed ID: 15948990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard guidelines of care: Keloids and hypertrophic scars.
    Gupta S; Sharma VK
    Indian J Dermatol Venereol Leprol; 2011; 77(1):94-100. PubMed ID: 21220896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in psoriasis: an analysis of Psocare project patients.
    Spandonaro F; Altomare G; Berardesca E; Calzavara-Pinton P; Chimenti S; Girolomoni G; Peserico A; Guerra AP; Vena GA; Polistena B; Ayala F
    G Ital Dermatol Venereol; 2011 Jun; 146(3):169-77. PubMed ID: 21566546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of active and stable psoriasis on health-related quality of life: the PSO-LIFE study.
    Daudén E; Herrera E; Puig L; Sánchez-Carazo JL; Toribio J; Perulero N
    Actas Dermosifiliogr; 2013 Oct; 104(8):685-93. PubMed ID: 23958428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study.
    Tang MM; Chang CC; Chan LC; Heng A
    Int J Dermatol; 2013 Mar; 52(3):314-22. PubMed ID: 23414155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Dermatology Life Quality Index and the Children's Dermatology Life Quality Index in assessment of quality of life in patients with psoriasis aged 16-17 years.
    van Geel MJ; Maatkamp M; Oostveen AM; de Jong EM; Finlay AY; van de Kerkhof PC; Seyger MM
    Br J Dermatol; 2016 Jan; 174(1):152-7. PubMed ID: 26361284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the Dermatology Life Quality Index (DLQI) in a midwestern US urban clinic.
    Hahn HB; Melfi CA; Chuang TY; Lewis CW; Gonin R; Hanna MP; Farmer ER
    J Am Acad Dermatol; 2001 Jul; 45(1):44-8. PubMed ID: 11423833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of psoriatic patients at risk of high quality of life impairment.
    Sojević Timotijević Z; Janković S; Trajković G; Majcan P; Perišić S; Dostanić N; Janićijević Hudomal S; Janković J
    J Dermatol; 2013 Oct; 40(10):797-804. PubMed ID: 23961725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analyses of the stratum corneum in scars. Sequential studies after injury and comparison among keloids, hypertrophic scars, and atrophic scars.
    Suetake T; Sasai S; Zhen YX; Ohi T; Tagami H
    Arch Dermatol; 1996 Dec; 132(12):1453-8. PubMed ID: 8961874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of psoriasis on quality of life in Iran.
    Aghaei S; Moradi A; Ardekani GS
    Indian J Dermatol Venereol Leprol; 2009; 75(2):220. PubMed ID: 19293529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of cryosurgery in keloids and hypertrophic scars. A prospective consecutive trial of case series.
    Zouboulis CC; Blume U; Büttner P; Orfanos CE
    Arch Dermatol; 1993 Sep; 129(9):1146-51. PubMed ID: 8363398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.